German Compassionate Use Program For Transcon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ascendis Pharma A/S (NASDAQ:ASND) Q2 2023 Earnings Call Transcript September 5, 2023 Ascendis Pharma A/S beats earnings expectations. Reported EPS is $2.16, expectations were $-2.68. Operator: Hello, and welcome to Ascendis Pharma Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a […] ....

United Kingdom , United States , Scott Smith , Yaron Werber , Li Watsek , Caroline Palomeque , Stina Singel , Jan Mikkelsen , Ascendis Pharma , Leland Gershell , Tim Lee , Paul Choi , David Lebovitz , Andreas Argyrides , Goldman Sachs , Meat Companies To , European Commission , Us Expanded Access Program , Head Of Clinical Development Oncology , European Union , German Compassionate Use Program For Transcon , Senior Director , Investor Relations , Chief Executive Officer , Executive Vice President , Chief Financial Officer ,